A Prospective, Randomized, Double Blind, Parallel Group Study to Establish the Therapeutic Equivalence of EPIAO With the Standard Treatment EPREX in Subjects With Chronic Kidney Disease (CKD) Related Anaemia Not Yet on Dialysis
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2016
At a glance
- Drugs Recombinant erythropoietin (Primary) ; Epoetin alfa
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms BEAT_001
- Sponsors Shenyang Sunshine Pharmaceutical
- 12 Oct 2016 Planned End Date changed from 1 Feb 2017 to 1 Aug 2018.
- 12 Oct 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Jun 2018.
- 12 Oct 2016 Status changed from not yet recruiting to recruiting.